|
2024
|
Invention
|
Vaccines against infectious diseases caused by positive stranded rna viruses.
Compositions for p... |
|
2023
|
Invention
|
Novel rna and dna technology for vaccination against alphaviruses and other emerging and epidemic... |
|
|
Invention
|
Recombinant bovine immunodeficiency virus-like particles comprising an influenza ha transmembrane... |
|
2018
|
Invention
|
Idna vaccines and methods for using the same. Described herein are iDNA vectors and vaccines and ... |
|
2017
|
Invention
|
Vaccines against infectious diseases caused by positive stranded rna viruses. Compositions for pr... |
|
2016
|
Invention
|
Recombinant bovine immunodeficiency virus gag virus-like particles containing influenza immunogen... |
|
|
Invention
|
Recombinant virus like particles using bovine immunodeficiency virus gag protein. Described herei... |
|
2015
|
Invention
|
Infectious dna vaccines against chikungunya virus. Described herein are i-DNA™ vectors and vaccin... |
|
2011
|
G/S
|
Adjuvants for use with vaccines; Oral vaccine preparations; Pharmaceutical preparations for the p... |
|
2005
|
Invention
|
Vector platforms derived from the alphavirus vaccines.
Nucleic acid molecules and vector platfor... |